Advertisement

Portal Vein Thrombosis: Recent Advance

  • Xingshun QiEmail author
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 906)

Abstract

Portal vein thrombosis is a life-threatening vascular disorder of the liver. In this chapter, I will review the recent advance regarding the epidemiology, etiology, management, and prognosis of portal vein thrombosis.

Keywords

Portal vein Splanchnic vein Thrombus Portal hypertension Liver Hepatic 

References

  1. Ageno W, Dentali F, De Stefano V et al (2014) Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria phenotype in patients with splanchnic vein thrombosis. Thromb Res 133:1052–1055CrossRefPubMedGoogle Scholar
  2. Ahluwalia J, Naseem S, Sachdeva MU et al (2014) Paroxysmal Nocturnal Hemoglobinuria is rare cause for thrombosis of the intra-abdominal veins in the ethnic Indian population – results from FLAER-based flowcytometry screening. Eur J Haematol 92:435–443CrossRefPubMedGoogle Scholar
  3. Amitrano L, Guardascione MA, Menchise A et al (2010) Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol 44:448–451PubMedGoogle Scholar
  4. Bizollon T, Bissuel F, Detry L, Trepo C (1991) Fibrinolytic therapy for portal vein thrombosis. Lancet 337:1416CrossRefPubMedGoogle Scholar
  5. Cao G, Ko GY, Sung KB, Yoon HK, Gwon DI, Kim JH (2013) Treatment of postoperative main portal vein and superior mesenteric vein thrombosis with balloon angioplasty and/or stent placement. Acta Radiol 54:526–532CrossRefPubMedGoogle Scholar
  6. Chen VT, Wei J, Liu YC (1992) A new procedure for management of extrahepatic portal obstruction. Proximal splenic-left intrahepatic portal shunt. Arch Surg 127:1358–1360CrossRefPubMedGoogle Scholar
  7. Chung JW, Kim GH, Lee JH et al (2014) Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis. Clin Mol Hepatol 20:384–391CrossRefPubMedPubMedCentralGoogle Scholar
  8. Condat B, Pessione F, Denninger MH, Hillaire S, Valla D (2000) Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology 32:466–470CrossRefPubMedGoogle Scholar
  9. Condat B, Pessione F, Hillaire S et al (2001) Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 120:490–497CrossRefPubMedGoogle Scholar
  10. de Franchis R (2010) Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 53:762–768CrossRefPubMedGoogle Scholar
  11. De Santis A, Moscatelli R, Catalano C et al (2010) Systemic thrombolysis of portal vein thrombosis in cirrhotic patients: a pilot study. Dig Liver Dis 42:451–455CrossRefPubMedGoogle Scholar
  12. De Stefano V, Martinelli I (2010) Splanchnic vein thrombosis: clinical presentation, risk factors and treatment. Intern Emerg Med 5:487–494CrossRefPubMedGoogle Scholar
  13. de Ville de Goyet J, Clapuyt P, Otte JB (1992) Extrahilar mesenterico-left portal shunt to relieve extrahepatic portal hypertension after partial liver transplant. Transplantation 53:231–232Google Scholar
  14. DeLeve LD, Valla DC, Garcia-Tsao G (2009) Vascular disorders of the liver. Hepatology 49:1729–1764CrossRefPubMedGoogle Scholar
  15. Delgado MG, Seijo S, Yepes I et al (2012) Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol 10:776–783CrossRefPubMedGoogle Scholar
  16. di Francesco F, Grimaldi C, de Ville de Goyet J (2014) Meso-Rex bypass – a procedure to cure prehepatic portal hypertension: the insight and the inside. J Am Coll Surg 218:e23–e36CrossRefPubMedGoogle Scholar
  17. Fimognari FL, Violi F (2008) Portal vein thrombosis in liver cirrhosis. Intern Emerg Med 3:213–218CrossRefPubMedGoogle Scholar
  18. Girleanu I, Stanciu C, Cojocariu C, Boiculese L, Singeap AM, Trifan A (2014) Natural course of nonmalignant partial portal vein thrombosis in cirrhotic patients. Saudi J Gastroenterol 20:288–292CrossRefPubMedPubMedCentralGoogle Scholar
  19. Guerin F, Bidault V, Gonzales E, Franchi-Abella S, De Lambert G, Branchereau S (2013) Meso-Rex bypass for extrahepatic portal vein obstruction in children. Br J Surg 100:1606–1613CrossRefPubMedGoogle Scholar
  20. Janssen HL, Wijnhoud A, Haagsma EB et al (2001) Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 49:720–724CrossRefPubMedPubMedCentralGoogle Scholar
  21. Lautz TB, Keys LA, Melvin JC, Ito J, Superina RA (2013) Advantages of the meso-Rex bypass compared with portosystemic shunts in the management of extrahepatic portal vein obstruction in children. J Am Coll Surg 216:83–89CrossRefPubMedGoogle Scholar
  22. Luca A, Caruso S, Milazzo M et al (2012) Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. Radiology 265:124–132CrossRefPubMedGoogle Scholar
  23. Maruyama H, Ishibashi H, Takahashi M, Shimada T, Kamesaki H, Yokosuka O (2012) Prediction of the therapeutic effects of anticoagulation for recent portal vein thrombosis: a novel approach with contrast-enhanced ultrasound. Abdom Imaging 37:431–438CrossRefPubMedGoogle Scholar
  24. Nery F, Chevret S, Condat B et al (2015) Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study. Hepatology 61:660–667CrossRefPubMedGoogle Scholar
  25. Ogren M, Bergqvist D, Bjorck M, Acosta S, Eriksson H, Sternby NH (2006) Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol 12:2115–2119CrossRefPubMedPubMedCentralGoogle Scholar
  26. Plessier A, Darwish-Murad S, Hernandez-Guerra M et al (2010) Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology 51:210–218CrossRefPubMedGoogle Scholar
  27. Qi X, Han G (2012) Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature. Hepatol Int 6:576–590CrossRefPubMedGoogle Scholar
  28. Qi X, Han G, Fan D (2010) The preferable treatment for cirrhotic portal vein thrombosis: anticoagulation or transjugular intrahepatic portosystemic shunt? Hepatology 51:713–714CrossRefPubMedGoogle Scholar
  29. Qi X, Bai M, Yang Z et al (2011) Occlusive portal vein thrombosis as a new marker of decompensated cirrhosis. Med Hypotheses 76:522–526CrossRefPubMedGoogle Scholar
  30. Qi X, Zhang C, Han G et al (2012) Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective study. J Gastroenterol Hepatol 27:1036–1043CrossRefPubMedGoogle Scholar
  31. Qi X, De Stefano V, Wang J et al (2013a) Prevalence of inherited antithrombin, protein C, and protein S deficiencies in portal vein system thrombosis and Budd-Chiari syndrome: a systematic review and meta-analysis of observational studies. J Gastroenterol Hepatol 28:432–442CrossRefPubMedGoogle Scholar
  32. Qi X, He C, Han G et al (2013b) Prevalence of paroxysmal nocturnal hemoglobinuria in Chinese patients with Budd-Chiari syndrome or portal vein thrombosis. J Gastroenterol Hepatol 28:148–152CrossRefPubMedGoogle Scholar
  33. Qi X, Chen H, Han G (2013c) Effect of antithrombin, protein C and protein S on portal vein thrombosis in liver cirrhosis: a meta-analysis. Am J Med Sci 346:38–44CrossRefPubMedGoogle Scholar
  34. Qi XS, Bai M, He CY et al (2013d) Prognostic factors in non-malignant and non-cirrhotic patients with portal cavernoma: an 8-year retrospective single-center study. World J Gastroenterol 19:7447–7454CrossRefPubMedPubMedCentralGoogle Scholar
  35. Qi X, Ren W, De Stefano V, Fan D (2014a) Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 12:1801–1812 e7CrossRefPubMedGoogle Scholar
  36. Qi X, Yang Z, De Stefano V, Fan D (2014b) Methylenetetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia in Budd-Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis of observational studies. Hepatol Res 44:E480–E498CrossRefPubMedGoogle Scholar
  37. Qi X, Bai M, Guo X, Fan D (2014c) Pharmacologic prophylaxis of portal venous system thrombosis after splenectomy: a meta-analysis. Gastroenterol Res Pract 2014:292689CrossRefPubMedPubMedCentralGoogle Scholar
  38. Qi X, Yang Z, Fan D (2014d) Spontaneous resolution of portal vein thrombosis in cirrhosis: where do we stand, and where will we go? Saudi J Gastroenterol 20:265–266CrossRefPubMedPubMedCentralGoogle Scholar
  39. Qi X, Wu F, He C, Fan D, Han G (2015a) Thrombotic risk factors in Chinese nonmalignant and noncirrhotic patients with portal vein thrombosis: an observational study with a systematic review of the literature. Eur J Gastroenterol Hepatol 27:77–83CrossRefPubMedGoogle Scholar
  40. Qi X, De Stefano V, Su C, Bai M, Guo X, Fan D (2015b) Associations of antiphospholipid antibodies with splanchnic vein thrombosis: a systematic review with meta-analysis. Medicine (Baltimore) 94:e496CrossRefGoogle Scholar
  41. Qi X, De Stefano V, Li H, Dai J, Guo X, Fan D (2015c) Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Eur J Intern Med 26:23–29CrossRefPubMedGoogle Scholar
  42. Rajani R, Bjornsson E, Bergquist A et al (2010) The epidemiology and clinical features of portal vein thrombosis: a multicentre study. Aliment Pharmacol Ther 32:1154–1162CrossRefPubMedGoogle Scholar
  43. Robin P, Gruel Y, Lang M, Lagarrigue F, Scotto JM (1988) Complete thrombolysis of mesenteric vein occlusion with recombinant tissue-type plasminogen activator. Lancet 1:1391CrossRefPubMedGoogle Scholar
  44. Rossle M (2013) TIPS: 25 years later. J Hepatol 59:1081–1093CrossRefPubMedGoogle Scholar
  45. Silva-Junior G, Turon F, Hernandez-Gea V, Darnell A, Garcia-Criado A, Garcia-Pagan JC (2014) Unexpected disappearance of portal cavernoma on long-term anticoagulation. J Hepatol 61:446–448CrossRefPubMedGoogle Scholar
  46. Smalberg JH, Spaander MV, Jie KS et al (2008) Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis. Thromb Haemost 100:1084–1088PubMedGoogle Scholar
  47. Smalberg JH, Arends LR, Valla DC, Kiladjian JJ, Janssen HL, Leebeek FW (2012) Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis. Blood 120:4921–4928CrossRefPubMedGoogle Scholar
  48. Spaander MC, van Buuren HR, Hansen BE, Janssen HL (2010) Ascites in patients with noncirrhotic nonmalignant extrahepatic portal vein thrombosis. Aliment Pharmacol Ther 32:529–534CrossRefPubMedGoogle Scholar
  49. Spaander MC, Hoekstra J, Hansen BE, Van Buuren HR, Leebeek FW, Janssen HL (2013) Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding. J Thromb Haemost 11:452–459CrossRefPubMedGoogle Scholar
  50. Tripodi A, Mannucci PM (2011) The coagulopathy of chronic liver disease. N Engl J Med 365:147–156CrossRefPubMedGoogle Scholar
  51. Tripodi A, Primignani M, Chantarangkul V et al (2009) An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology 137:2105–2111CrossRefPubMedGoogle Scholar
  52. Villa E, Camma C, Marietta M et al (2012) Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology 143:1253–1260CrossRefPubMedGoogle Scholar
  53. Wang MQ, Guo LP, Lin HY, Liu FY, Duan F, Wang ZJ (2010) Transradial approach for transcatheter selective superior mesenteric artery urokinase infusion therapy in patients with acute extensive portal and superior mesenteric vein thrombosis. Cardiovasc Intervent Radiol 33:80–89CrossRefPubMedGoogle Scholar
  54. Wang MQ, Liu FY, Duan F, Wang ZJ, Song P, Fan QS (2011) Acute symptomatic mesenteric venous thrombosis: treatment by catheter-directed thrombolysis with transjugular intrahepatic route. Abdom Imaging 36:390–398CrossRefPubMedGoogle Scholar
  55. Wang J, Yang W, Huang Q et al (2015) Interventional treatment for portal venous occlusion after liver transplantation: long-term follow-up results. Medicine (Baltimore) 94:e356CrossRefGoogle Scholar
  56. Zhu K, Meng X, Zhou B et al (2013) Percutaneous transsplenic portal vein catheterization: technical procedures, safety, and clinical applications. J Vasc Interv Radiol 24:518–527CrossRefPubMedGoogle Scholar
  57. Ziakas PD, Poulou LS, Rokas GI, Bartzoudis D, Voulgarelis M (2007) Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks, outcome. An overview. J Thromb Haemost 5:642–645CrossRefPubMedGoogle Scholar
  58. Zocco MA, Di Stasio E, De Cristofaro R et al (2009) Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 51:682–689CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of GastroenterologyGeneral Hospital of Shenyang Military AreaShenyangChina

Personalised recommendations